Cargando…

HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts

A substantial proportion of persons living with HIV/AIDS (PLHA) delay, decline, or discontinue antiretroviral therapy (ART) when it is medically indicated (40–45%), largely African-Americans and Latinos/Hispanics. This study explores the feasibility of locating PLHA, who are not on ART (PLHA-NOA) th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwadz, Marya, Applegate, Elizabeth, Cleland, Charles, Leonard, Noelle Regina, Wolfe, Hannah, Salomon, Nadim, Belkin, Mindy, Riedel, Marion, Banfield, Angela, Sanfilippo, Lisa, Wagner, Andrea, Mildvan, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100062/
https://www.ncbi.nlm.nih.gov/pubmed/25077137
http://dx.doi.org/10.3389/fpubh.2014.00081
_version_ 1782326606167015424
author Gwadz, Marya
Applegate, Elizabeth
Cleland, Charles
Leonard, Noelle Regina
Wolfe, Hannah
Salomon, Nadim
Belkin, Mindy
Riedel, Marion
Banfield, Angela
Sanfilippo, Lisa
Wagner, Andrea
Mildvan, Donna
author_facet Gwadz, Marya
Applegate, Elizabeth
Cleland, Charles
Leonard, Noelle Regina
Wolfe, Hannah
Salomon, Nadim
Belkin, Mindy
Riedel, Marion
Banfield, Angela
Sanfilippo, Lisa
Wagner, Andrea
Mildvan, Donna
author_sort Gwadz, Marya
collection PubMed
description A substantial proportion of persons living with HIV/AIDS (PLHA) delay, decline, or discontinue antiretroviral therapy (ART) when it is medically indicated (40–45%), largely African-Americans and Latinos/Hispanics. This study explores the feasibility of locating PLHA, who are not on ART (PLHA-NOA) through clinics and peer-referral; compares the two cohorts on multi-level barriers to ART; and examines readiness to initiate/reinitiate ART, a predictor of treatment outcomes. We recruited adult HIV-infected African-American and Latino/Hispanic PLHA-NOA through HIV hospital clinics and peer-referral in 2012–2013. Participants were engaged in structured 1-h assessments with reliable/valid measures on barriers to ART. We found that recruitment through peers (63.2%, 60/95) was more feasible than in clinics (36.8%, 35/90). Participants were 48.0 years old and had lived with HIV for 14.7 years on average, and 56.8% had taken ART previously. Most (61.1%) were male and African-American (76.8%), and 23.2% were Latino/Hispanic. Peer-recruited participants were older, had lived with HIV longer, were less engaged in HIV care, and were more likely to have taken ART previously. The cohorts differed in reasons for discontinuing ART. Levels of ART knowledge were comparable between cohorts (68.5% correct), and there were no differences in attitudes toward ART (e.g., mistrust), which were in the neutral range. In bivariate linear regression, readiness for ART was negatively associated with physician mistrust (B = −10.4) and positively associated with self-efficacy (B = 5.5), positive outcome expectancies (B = 6.3), beliefs about personal necessity of ART (B = 17.5), and positive internal norms (B = 7.9). This study demonstrates the feasibility of engaging this vulnerable population through peer-referral. Peer-recruited PLHA evidence particularly high rates of risk factors compared to those in hospital clinics. Interventions to support ART initiation and continuation are sorely needed for both subgroups.
format Online
Article
Text
id pubmed-4100062
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-41000622014-07-30 HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts Gwadz, Marya Applegate, Elizabeth Cleland, Charles Leonard, Noelle Regina Wolfe, Hannah Salomon, Nadim Belkin, Mindy Riedel, Marion Banfield, Angela Sanfilippo, Lisa Wagner, Andrea Mildvan, Donna Front Public Health Public Health A substantial proportion of persons living with HIV/AIDS (PLHA) delay, decline, or discontinue antiretroviral therapy (ART) when it is medically indicated (40–45%), largely African-Americans and Latinos/Hispanics. This study explores the feasibility of locating PLHA, who are not on ART (PLHA-NOA) through clinics and peer-referral; compares the two cohorts on multi-level barriers to ART; and examines readiness to initiate/reinitiate ART, a predictor of treatment outcomes. We recruited adult HIV-infected African-American and Latino/Hispanic PLHA-NOA through HIV hospital clinics and peer-referral in 2012–2013. Participants were engaged in structured 1-h assessments with reliable/valid measures on barriers to ART. We found that recruitment through peers (63.2%, 60/95) was more feasible than in clinics (36.8%, 35/90). Participants were 48.0 years old and had lived with HIV for 14.7 years on average, and 56.8% had taken ART previously. Most (61.1%) were male and African-American (76.8%), and 23.2% were Latino/Hispanic. Peer-recruited participants were older, had lived with HIV longer, were less engaged in HIV care, and were more likely to have taken ART previously. The cohorts differed in reasons for discontinuing ART. Levels of ART knowledge were comparable between cohorts (68.5% correct), and there were no differences in attitudes toward ART (e.g., mistrust), which were in the neutral range. In bivariate linear regression, readiness for ART was negatively associated with physician mistrust (B = −10.4) and positively associated with self-efficacy (B = 5.5), positive outcome expectancies (B = 6.3), beliefs about personal necessity of ART (B = 17.5), and positive internal norms (B = 7.9). This study demonstrates the feasibility of engaging this vulnerable population through peer-referral. Peer-recruited PLHA evidence particularly high rates of risk factors compared to those in hospital clinics. Interventions to support ART initiation and continuation are sorely needed for both subgroups. Frontiers Media S.A. 2014-07-16 /pmc/articles/PMC4100062/ /pubmed/25077137 http://dx.doi.org/10.3389/fpubh.2014.00081 Text en Copyright © 2014 Gwadz, Applegate, Cleland, Leonard, Wolfe, Salomon, Belkin, Riedel, Banfield, Sanfilippo, Wagner, Mildvan and The Heart to Heart Collaborative Research Team. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Gwadz, Marya
Applegate, Elizabeth
Cleland, Charles
Leonard, Noelle Regina
Wolfe, Hannah
Salomon, Nadim
Belkin, Mindy
Riedel, Marion
Banfield, Angela
Sanfilippo, Lisa
Wagner, Andrea
Mildvan, Donna
HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts
title HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts
title_full HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts
title_fullStr HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts
title_full_unstemmed HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts
title_short HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts
title_sort hiv-infected individuals who delay, decline, or discontinue antiretroviral therapy: comparing clinic- and peer-recruited cohorts
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100062/
https://www.ncbi.nlm.nih.gov/pubmed/25077137
http://dx.doi.org/10.3389/fpubh.2014.00081
work_keys_str_mv AT gwadzmarya hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT applegateelizabeth hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT clelandcharles hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT leonardnoelleregina hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT wolfehannah hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT salomonnadim hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT belkinmindy hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT riedelmarion hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT banfieldangela hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT sanfilippolisa hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT wagnerandrea hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT mildvandonna hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts
AT hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts